Atlas Trials

KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer

Clinical trial NCT02205463 · WITHDRAWN

Trial details

NCT number
NCT02205463
Sponsor
NYU Langone Health
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal CancerStomach Cancer
Start date
2014-12-01
Primary completion
2017-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.